The company's purpose is the import, manufacture and distribution of pharmaceutical and veterinary products as well as medical devices and instruments, in particular contrast agents and related accessories. The main activity is the distribution of contrast agents; the primary sales region is domestic and the key end customers are hospitals and office-based radiologists. Procurement is carried out predominantly from intra-group suppliers; the company is part of the Guerbet S.A. group, which is listed on the Paris stock exchange. Research and development is not performed internally but is coordinated at the group's top-level company.
Einfuhr, die Herstellung und der Vertrieb von pharmazeutischen, chemischen, veterinärmedizinischen, diätetischen Gegenständen, Gegenständen für bildgebende Verfahren, Erzeugnissen und medizinischen Geräten und Instrumenten aller Art einschließlich Zubehör, sowie die Ausübung aller hiermit zusammenhängenden Dienstleistungen und Tätigkeiten.
Converted using the official Destatis and Eurostat correspondence tables; ISIC Rev. 4 is the United Nations' international industry classification.
This summary was generated with the help of AI. See our Data Quality Notice. Report error?
Source: German Commercial Register (Handelsregister) Frankfurt am Main Local Court, HRB 109368 (as of 30 October 2026)
| Name | Type | City |
|---|---|---|
| Susanne Jessen | Geschäftsführer(in) | Hamburg |
| Adriano Mendes Caldas | Geschäftsführer(in) | Saint Germain en Laye |
Source: German Commercial Register (Handelsregister) Frankfurt am Main Local Court, HRB 109368 (as of 30 October 2026)
| Date | Event Type | Event |
|---|---|---|
| 13.10.2017 | Business Address Change | Otto-Volger-Straße 11, 65843 Sulzbach (Taunus) |
| 18.08.2017 | Company Name Registered | Guerbet GmbH |
| 18.08.2017 | Registered Seat | Sulzbach (Taunus) |
| Date | Type | Change | Total Capital |
|---|---|---|---|
| 18.08.2017 | Share Capital Set | — | 25.000 € |
| Date | Contract | Value |
|---|---|---|
| 3.3.2026 | Supplier · PBMG eG | — |
Source: German Commercial Register (Handelsregister) Frankfurt am Main Local Court, HRB 109368 (as of 30 October 2026)
| Year | Revenue | Profit | Balance | Employees |
|---|---|---|---|---|
| 2024 | Rohergebnis€11.2M2 | €1,795,763 | €25,517,651 | — |
| 2023 | Rohergebnis€12.1M2 | €2,853,024 | €26,387,882 | — |
| 2022 | Rohergebnis€8.9M2 | €845,541 | €23,171,924 | — |
| 2021 | Rohergebnis€9.1M2 | €759,361 | €36,436,339 | — |
| 2020 | Rohergebnis€7.9M2 | €583,226 | €33,063,576 | — |
| 2019 | €39,182,553 | €2,482,410 | €33,735,676 | — |
| 2018 | €43,678,735 | €1,956,514 | €35,768,656 | — |
| 2017 | €57,315,927 | €3,103,339 | €45,993,771 | — |
| 2016 | €2,687,160 | €435,782 | €7,408,583 | — |
| 2015 | €7,627,164 | €337,825 | €8,401,375 | — |
2 Rohergebnis nach § 276 HGB: Umsatzerlöse abzüglich Materialaufwand bzw. Herstellungskosten. Kleine und mittelgroße Kapitalgesellschaften dürfen diese Posten zusammenfassen; die Umsatzerlöse selbst sind dann nicht veröffentlicht und liegen über dem Rohergebnis.
Sign in to download data
Source: German Commercial Register (Handelsregister) Frankfurt am Main Local Court, HRB 109368 (as of 30 October 2026)
| Cost type | Amount | Share |
|---|---|---|
| Personnel Costs | €4,787,784 | 95.4% |
| Depreciation | €17,162 | 0.3% |
| Interest & Similar | €215,430 | 4.3% |
